Osteoarthritis is the most common degenerative joint disease, affecting 22% of adults over 40 globally. Although the condition has been extensively studied through a medical perspective, the molecular changes associated with osteoarthritis remain unclear.
Bright Health sells Medicare Advantage plans to Molina for $600 million
Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare. Regulators must approve the deal. But the